Cargando…
Uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in COVID-19 patients
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425761/ http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.180 |
_version_ | 1784778520034017280 |
---|---|
author | Shalaeva, E.V. Shamsutdinova, M.I. Azizova, F.L. Teshaev, O.R. Boymuradov, S.A. Saner, H. |
author_facet | Shalaeva, E.V. Shamsutdinova, M.I. Azizova, F.L. Teshaev, O.R. Boymuradov, S.A. Saner, H. |
author_sort | Shalaeva, E.V. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9425761 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94257612022-08-30 Uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in COVID-19 patients Shalaeva, E.V. Shamsutdinova, M.I. Azizova, F.L. Teshaev, O.R. Boymuradov, S.A. Saner, H. Atherosclerosis Article Published by Elsevier B.V. 2022-08 2022-08-30 /pmc/articles/PMC9425761/ http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.180 Text en Copyright © 2022 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Shalaeva, E.V. Shamsutdinova, M.I. Azizova, F.L. Teshaev, O.R. Boymuradov, S.A. Saner, H. Uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in COVID-19 patients |
title | Uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in COVID-19 patients |
title_full | Uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in COVID-19 patients |
title_fullStr | Uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in COVID-19 patients |
title_full_unstemmed | Uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in COVID-19 patients |
title_short | Uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in COVID-19 patients |
title_sort | uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in covid-19 patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425761/ http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.180 |
work_keys_str_mv | AT shalaevaev uncontrolledvscontrolledtype2diabetesandincreasedriskof30daysallcausemortalityincovid19patients AT shamsutdinovami uncontrolledvscontrolledtype2diabetesandincreasedriskof30daysallcausemortalityincovid19patients AT azizovafl uncontrolledvscontrolledtype2diabetesandincreasedriskof30daysallcausemortalityincovid19patients AT teshaevor uncontrolledvscontrolledtype2diabetesandincreasedriskof30daysallcausemortalityincovid19patients AT boymuradovsa uncontrolledvscontrolledtype2diabetesandincreasedriskof30daysallcausemortalityincovid19patients AT sanerh uncontrolledvscontrolledtype2diabetesandincreasedriskof30daysallcausemortalityincovid19patients |